Speaker illustration

Doctor Maria Stefil

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
European Heart Rythm Association

Dr Maria Stefil graduated with an MBBS with Distinction from the University East Anglia (UEA) in 2020 and is currently an Academic Foundation Trainee in the North West of England. In 2021 she joined the Liverpool Centre for Cardiovascular Science as a Clinical Research Fellow and has been working on the ABC Pathway trials in atrial fibrillation as a member of Professor Gregory Lip's team. Dr Stefil also holds a BSc in Biomedical Sciences from the University of Edinburgh and an MRes in Clinical Science with Distinction from UEA. Whilst at UEA she undertook heart failure research under the supervision of Professor Marcus Flather. In 2019 she received the Wolfson Award from the Royal College of Physicians to support her work with the Arterial Revascularisation Trial team at the University of Oxford. Dr Stefil is an Honorary Research Fellow at the University of Liverpool School of Medicine where she has roles as an academic supervisor and examiner.

Effects of the Atrial fibrillation Better Care (ABC) pathway on outcomes among clinically complex chinese patients with atrial fibrillation with multimorbidity and polypharmacy.

Event: EHRA 2022

Topic: Clinical

Session: ePosters Day 2

Thumbnail

Effects of diabetes and obesity in patients undergoing coronary artery bypass graft surgery: ten-year results from the Arterial Revascularisation Trial.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Coronary Arteries

Session: Coronary Bypass Surgery: Optimizing Perioperative Management

Thumbnail

Outcomes after coronary artery bypass graft surgery: systematic review and meta-analysis comparing bilateral versus single internal thoracic artery grafts

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Coronary Arteries

Session: Cardiovascular Surgery ePosters

Thumbnail

This platform is supported by

logo Novo Nordisk